Additional file 1 of Long-term prognosis in patients with acute myocardial infarction and newly detected glucose abnormalities: predictive value of oral glucose tolerance test and HbA1c

Additional file 1: Figure S1. Flowchart for the study population. Table S1. Definitions of normal glycaemic status and dysglycaemia according to ADA and WHO criteria. Table S2. List of ICD-10 codes and definitions used in our study. Table S3. Baseline characteristics of all patients screened with OGTT (n =1 684) stratified by glycaemic status according to ADA criteria. Table S4. Absolute numbers (%), event rates per 100 person-years and hazard ratios for all-cause mortality in 841 patients stratified by glucose perturbation group according to OGTT and HbA1c results (ADA criteria). Figure S2. Kaplan–Meier curve showing time to freedom from all-cause mortality for different categories of dysglycaemia according to A. Fasting and 2-hour post-load glucose results (OGTT) and B. HbA1c. Table S5. Absolute numbers (%), event rates per 100 person-years and hazard ratios for the combined event (CE; first of myocardial infarction, hospitalisation for heart failure, ischaemic stroke or mortality) in 1684 patients stratified by glucose perturbation group according to OGTT (ADA criteria).